Meeting Banner
Abstract #0501

Dual PI3K/mTOR Inhibition Suppresses Tumor PO2 Within Viable Tumor Assessed by 19F-MRI and Multispectral Analysis

Yunzhou Shi1, Jason Oeh2, Jeffrey Eastham-Anderson3, Sharon Yee2, David Finkle2, Franklin V. Peale3, Jed Ross1, Maj Hedehus1, Nicholas van Bruggen1, Rayna Venook2, Sarajane Ross2, Deepak Sampath2, Richard A. D. Carano4

1Biomedical Imaging, Genentech Inc.(Roche Group), South San Francisco, CA, United States; 2Translational Oncology, Genentech Inc.(Roche Group), South San Francisco, CA, United States; 3Pathology, Genentech Inc.(Roche Group), South San Francisco, CA, United States; 4Biomedical Imaging, Genentech, South San Francisco, CA, United States

The effect of a novel dual PI3K/mTOR inhibitor on tumor oxygen level was studied using a novel approach that combines 19F-MRI T1 mapping with diffusion-based multispectral K-means clustering. The current study aims to elucidate the role of PI3K/mTOR signaling on oxygen level in viable tumor. An anti-angiogenic agent, B20.4.1.1, was employed as a positive control for its known anti-vascular effects. We were able to monitor pO2 for 72h without fluorine signal loss. The current results advocate for the use of the multispectral 19F-MRI technique as a tool to better understand the mode of action of therapies that alter tumors microenvironment.

Keywords

addition adipose administered agents aims alter anatomical animal animals anti apparent appears approved better biomedical block blocks cancer care cell cells class classes clustering coefficient coil combined committee consumption containing control course cutaneous days decrease decreased density described diffusion dose dual elucidate employed enabled endothelial equipped error ether exhibited fast fluorine franklin function functional general generate growth heterogeneous human in vivo induced inhibition inhibitor injected injection inoculated institutional intensity intracellular intravenous intravenously inversion known likely limb loss mammalian mapping maps matrix metabolism mice mode mono nature necrosis necrotic novel nude oxygen pathway populations positive post previous previously prior proof quantify ragweed ranging receptor recovery reduces reduction remains representative respectively response reviews role samples segmentation segmented shot since slice slices south spatial spin stable strong strongly subcutaneously supply suppresses suppressing suppression surface system target technologies therapies therapy thick throughout tissue together tool towards translational treatment treatments trend tumor tumors tween understand variability vascular viable